Updated: June 13, 2026
Eos BioInnovation logo
Venture Capital Firm
CGT
Pharmaceuticals

Eos BioInnovation

About the program

Investment stage
Description

We are a regenerative medicine focussed fund backed by Panacea Venture. Our team, partners, and advisors are individually successful as investors, scientists, and entrepreneurs.

Location

Program details

Value add

We actively support our founders and portfolio companies at the early stage and help guide the team as needed. We take board seats and board observer roles.

Investment offer

Check size$250 – $1,000,000
Can lead rounds
Yes
Lead preference
Sometimes
Funding requirements

We invest in early-stage companies emerging from leading academic labs and research institutions in the field of regenerative medicine. We focus on therapies and technologies that can repair, replace, or regenerate organs, tissues, cells, and/or genes with the goal of treating the root causes of disease, rather than managing symptoms.